Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-194943
Filing Date
2022-07-15
Accepted
2022-07-15 16:09:05
Documents
16
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d361552d10ka.htm   iXBRL 10-K/A 504629
2 EX-31.3 d361552dex313.htm EX-31.3 3712
3 EX-31.4 d361552dex314.htm EX-31.4 3709
  Complete submission text file 0001193125-22-194943.txt   758091

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tyme-20220331.xsd EX-101.SCH 4595
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tyme-20220331_cal.xml EX-101.CAL 670
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tyme-20220331_def.xml EX-101.DEF 1675
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyme-20220331_lab.xml EX-101.LAB 20357
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyme-20220331_pre.xml EX-101.PRE 16413
10 EXTRACTED XBRL INSTANCE DOCUMENT d361552d10ka_htm.xml XML 8356
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

EIN.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-38169 | Film No.: 221086399
SIC: 2834 Pharmaceutical Preparations